Screener
Absci Corporation ABSI Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Absci Corporation in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent.
The source filing: Absci Corporation’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:08 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001672688-26-000136
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $7,156 | 2,756 |
| Accrued compensation | 3,471 | 6,615 |
| Accrued preclinical and clinical development expenses | 1,835 | 6,350 |
| Accrued other | 3,795 | 3,627 |
| Total accounts payable and accrued expenses | $16,257 | $19,348 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Absci Corporation's accrued expenses?
- Absci Corporation (ABSI) reported accrued expenses of $3.8M in Q2 2026.
- How has Absci Corporation's accrued expenses changed year-over-year?
- Absci Corporation's accrued expenses decreased by 33.6% year-over-year, from $5.72M to $3.8M.
- What is the long-term trend for Absci Corporation's accrued expenses?
- Over 5 years (2020 to 2025), Absci Corporation's accrued expenses has grown at a 18.2% compound annual growth rate (CAGR), from $1.57M to $3.63M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Absci Corporation's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude